Decrease of parafollicular thyroid C-cells in experimental esophageal atresia: further evidence of a neural crest pathogenic pathway.
Adriamycin-induced experimental esophageal atresia (EA) is often associated with malformations of neural crest (NC) origin, such as abnormal pharyngeal pouch derivatives like the thymus and the parathyroids. The aim of the present study was to examine whether NC-derived thyroid C-cells were abnormal in a rat model. Pregnant rats received intraperitoneally either 2 mg/kg Adriamycin (EA) or vehicle (controls) on days 8 and 9 of gestation. Fetuses were recovered on day 21, and blocks including the trachea and thyroid were fixed in formalin, coronally sectioned at 3-mum widths, and stained with standard hematoxylin and eosin until the largest area of thyroid was reached. From this point on, the 1st, 10th, and 20th slices were immunohistochemically stained with anti-calcitonin antibody. Positively-stained cells in each section of the gland were counted using a computer-assisted image analysis method, and the results were averaged. The distribution of the cells within the gland was assessed as well. Comparisons between EA and control rats were made by nonparametric tests with a significance threshold of p<0.05. The number of C-cells was dramatically reduced in EA animals compared with controls (32.4+/-36 vs. 92.3+/-60.5, p<0.001). Histology of the thyroid was similar in both groups, but the distribution of positive C-cells within the gland followed an abnormal pattern in EA rats. Adriamycin causes a pattern of NC-derived malformations, including a severe decrease in thyroid C-cells accompanied by abnormal distribution or migration patterns. These results represent further evidence of the involvement of NC organogenic control dysregulation in the pathogenesis of EA and its associated malformations. The similarities between the rat model and the clinical picture strongly support investigating other subclinical NC-derived anomalies in patients with EA.
Martinez
L
L
Department of Pediatric Surgery, Hospital Universitario, La Paz, P. de la Castellana 261, 28046 Madrid, Spain.
Ceano-Vivas
M De
MD
Gonzalez-Reyes
S
S
Hernandez
F
F
Fernandez-Dumont
V
V
Calonge
W M
WM
Ruiz
E
E
Rodriguez
J I
JI
Tovar
J A
JA
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity; D000906:Antibodies / Q000276:immunology; D002116:Calcitonin / Q000276:immunology / Q000378:metabolism; D002452:Cell Count; D004195:Disease Models, Animal; D004317:Doxorubicin / Q000633:toxicity; D004933:Esophageal Atresia / Q000139:chemically induced / Q000150:complications / Q000473:pathology*; D005260:Female; D005865:Gestational Age; D007150:Immunohistochemistry; D009432:Neural Crest / Q000002:abnormalities* / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013959:Thyroid Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D013961:Thyroid Gland / Q000002:abnormalities / Q000187:drug effects / Q000473:pathology*
D000903:Antibiotics, Antineoplastic; D000906:Antibodies; D004317:Doxorubicin; D002116:Calcitonin